Research programme: staphylococcal infections - InterMune/Panorama Research

Drug Profile

Research programme: staphylococcal infections - InterMune/Panorama Research

Alternative Names: Staphylococcal infections research programme - InterMune/Panorama Research

Latest Information Update: 21 May 2004

Price : $50

At a glance

  • Originator InterMune; Panorama Research
  • Class Small molecules; Vaccines
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Staphylococcal infections

Most Recent Events

  • 31 Dec 2003 Discontinued - Preclinical for Staphylococcal infections in USA (unspecified route)
  • 12 Apr 2002 Panorama Research added as research collaboration partner.
  • 26 Jan 2000 Preclinical development for Staphylococcal infections in USA (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top